Eylea vs Lucentis for Treatment-Naive Neovascular AMDEylea vs Lucentis for Treatment-Naive Neovascular AMD

A new study compares outcomes between these two drugs in previously untreated patients with neovascular AMD. How do they stack up? BMC Ophthalmology
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology Journal Article Source Type: news